Project Details
Description
A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naive, Male Pediatric Patients Without Severe Symptoms (FIELD)
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/13 → 12/31/17 |
Funding
- GENZYME CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.